FLAMMA is a family owned & run, award winning, fully integrated CDMO with Headquarters located near Milan, Italy. FLAMMA specializes in the cGMP manufacturing of small molecule APIs, NCEs, RSMs & advanced intermediates. FLAMMA has significant expertise in high value chiral materials (specifically amino acid related materials used in peptide drugs). FLAMMA provides manufacturing options for the entire life cycle of a small molecule drug.

FLAMMA can provide assistance for early stage pre-clinical development (from g to kg using our facility located outside of Philadelphia in the USA) to large-scale commercial manufacturing (from 100’s of kg to MT) at one of our three facilities located in Italy. FLAMMA’s 100% owned and self-managed facility in Dalian, China allows one to leverage its offerings to provide a stable and secure supply chain. With over 850 employees and a total capacity of 1,100 m3 (900 m3 in Italy and 200 m3 in China), learn why FLAMMA is a preferred supplier to the pharmaceutical and biotech industry. Visit FlammaGroup.com for further information.

Type of Drugs Manufactured:

Small Molecule

CDMO Services offer:

Drug Substance Manufacturing (API)

No. of Manufacturing Facilities:

3-5

High Potent Products capabilities:

OEB 3;OEB 4-5

Facilities Locations:

Europe;North America;China

Current Capacity: